Wednesday, February 12, 2014 6:34:18 PM
http://www.nanoviricides.com/otherofficers.html
"Thereafter, he was Group Leader, Cancer In Vivo Research and Clinical Development, at Eli Lilly and Company during 1995-2001. He was responsible for the development of the anticancer drugs Cryptophycin and the blockbusters, Gemzar and Alimta."
Before it was approved Alimta was known as LY231514.
Here is a paper from 2000 about this showing Krishna Menon as a coauthor from Lily.
http://clincancerres.aacrjournals.org/content/6/3/1016.long
Here is one of his patents:
Filed: May 14, 2010
"By all means let's be open-minded, but not so open-minded that our brains drop out." - Richard Dawkins
Recent NNVC News
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
